Becker Muscular Dystrophy Clinical Trial
Official title:
Fast Troponin as a Biomarker to Assess Exercise-induced Muscle Damage in Muscle Diseases
The purpose of the study is to explore the biomarker Fast Troponins response to exercise in patients with Becker muscular dystrophy, Limb-girdle muscular dystrophy and McArdle disease
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT01168908 -
Revatio for Heart Disease in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
|
Phase 2 | |
| Recruiting |
NCT01484678 -
Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy
|
||
| Completed |
NCT02147639 -
Effects of Sodium Nitrate on Blood Flow in Becker Muscular Dystrophy
|
Phase 2/Phase 3 | |
| Completed |
NCT02847975 -
Sodium Nitrate to Improve Blood Flow
|
Phase 1 | |
| Recruiting |
NCT02069756 -
The Duchenne Registry
|
||
| Completed |
NCT04585464 -
A Study to Assess Safety, Tolerability, and PK of EDG-5506 in Healthy Volunteers and Becker Muscular Dystrophy Adults
|
Phase 1 | |
| Recruiting |
NCT04668716 -
Brain Involvement in Dystrophinopathies Part 2
|
||
| Completed |
NCT03236662 -
(-)- Epicatechin Becker Muscular Dystrophy
|
Phase 2 | |
| Completed |
NCT01350154 -
Effect of Modulating the nNOS System on Cardiac, Muscular and Cognitive Function in Becker Muscular Dystrophy Patients
|
Phase 2 | |
| Enrolling by invitation |
NCT06066580 -
Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy
|
Phase 2 | |
| Not yet recruiting |
NCT06363526 -
Effectiveness of 5-week Digital Respiratory Practice in a Group of Children With Duchenne Muscular Dystrophy and Becker Muscular Dystrophy.
|
N/A | |
| Recruiting |
NCT05409079 -
Schulze Muscular Dystrophy Ability Clinical Study
|
N/A | |
| Completed |
NCT01856868 -
Use of (-)-Epicatechin in the Treatment of Becker Muscular Dystrophy (Pilot Study)
|
Phase 1/Phase 2 | |
| Completed |
NCT01557400 -
Study of Ataluren for Previously Treated Participants With Nonsense Mutation Duchenne/Becker Muscular Dystrophy (nmDBMD) in Europe, Israel, Australia, and Canada
|
Phase 3 | |
| Recruiting |
NCT02109692 -
Evaluation of Muscle miRNA as Biomarkers in Dystrophinopathies
|
N/A | |
| Recruiting |
NCT03057002 -
UTSW HP [13-C] Pyruvate Injection in HCM
|
||
| Recruiting |
NCT04583917 -
Brain Involvement in Dystrophinopathies Part 1
|
||
| Withdrawn |
NCT03076814 -
Functional Muscle Ischemia With Tadalafil Treatment in Becker Muscular Dystrophy
|
N/A | |
| Completed |
NCT02207283 -
PDE5 Inhibition to Alleviate Functional Muscle Ischemia in Becker Muscular Dystrophy
|
Phase 4 | |
| Completed |
NCT00873782 -
Safety Study of Transvenous Limb Perfusion in Human Muscular Dystrophy
|
Phase 1 |